N-Palmitoyl-D-erythro-sphingosine

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C34H67NO3
Molecular Weight	537.9007
Optical Activity	( - )
Defined Stereocenters	2 / 2
E/Z Centers	1
Charge	0

SHOW SMILES / InChI

Structure of N-Palmitoyl-D-erythro-sphingosine

Structure Search

SMILES

CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)\C=C\CCCCCCCCCCCCC

InChI

InChIKey=YDNKGFDKKRUKPY-TURZORIXSA-N

InChI=1S/C34H67NO3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-33(37)32(31-36)35-34(38)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h27,29,32-33,36-37H,3-26,28,30-31H2,1-2H3,(H,35,38)/b29-27+/t32-,33+/m0/s1

HIDE SMILES / InChI

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Apoptosis 155 Target ID: map04210 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22419109	Activator 1430

PubMed

Title	Date	PubMed

Name

Type

Language

N-Palmitoyl-D-erythro-sphingosine

Common Name

English

C16-Ceramide

Common Name

English

N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]hexadecanamide

Systematic Name

English

Hexadecanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-

Systematic Name

English

C16 Ceramide (d18:1/16:0)

Common Name

English

Code System Code Type Description

FDA UNII

FD38GFZ87C

Created by admin on Sat Dec 16 20:11:32 GMT 2023 , Edited by admin on Sat Dec 16 20:11:32 GMT 2023

PRIMARY

PUBCHEM

5283564

Created by admin on Sat Dec 16 20:11:32 GMT 2023 , Edited by admin on Sat Dec 16 20:11:32 GMT 2023

PRIMARY

CAS

24696-26-2

Created by admin on Sat Dec 16 20:11:32 GMT 2023 , Edited by admin on Sat Dec 16 20:11:32 GMT 2023

PRIMARY

SUBSTANCE RECORD


					FD38GFZ87C

N-Palmitoyl-D-erythro-sphingosine